Eric A. Rose

Eric Rose "is an academic physician and entrepreneur with interests in drug discovery, biodefense, clinical evaluative research and health policy. Since 2007, he has been the Executive Vice President for Life Sciences at MacAndrews & Forbes and CEO of Siga Technologies, Inc., an investment of MacAndrews & Forbes that develops anti-viral drugs directed at potential agents of bioterror. He was appointed in 2007 to the National Biodefense Science Board, which advises the HHS Secretary on biodefense, influenza, and emerging diseases. In 2008, he assumed the chairmanship of the Department of Health Policy at the Mount Sinai School of Medicine."

"Dr. Rose is a director of Abiomed, Inc. and Keryx Biopharmaceuticals, Inc. Dr. Rose is a graduate of both Columbia College and Columbia University College of Physicians & Surgeons."